@FiercePharma: Embattled Zoetis beats Q4 expectations, but tempers 2015 forecasts. FierceAnimalHealth story | Follow @FiercePharma
@CarlyHFierce: In merely one week from THIS very moment, you could be listening to me moderate this super cool webinar: … Sign up! | Follow @CarlyHFierce
> Hospira ($HSP) reported better-than-expected Q4 earnings, one week after Pfizer ($PFE) agreed to shell out $16 billion for the Lake Forest, IL-based drugmaker. More
> Teva ($TEVA) paid its highest salary last year, $7.3 million, to Allan Oberman, the company's former president and CEO of Teva Americas Generics. Story
> Sanofi ($SNY) is facing generic competition in the U.K. for Renvela, its chronic kidney disease drug, as cheaper versions of the med hit the market. Article
> Janssen and Saudi Arabia-based Riyadh Pharma inked a 5-year deal for Riyadh to manufacture and market some of Janssen's products in that country. Story
> India's Natco Pharma posted disappointing third quarter 2014 earnings, with profit falling 52% to $2.3 million from $4.8 million and net sales dropping 1% to 29.7 million. More
> Researchers at the University of Florida found that using the Type 2 diabetes drug metformin in combination with a glucose inhibitor could help reverse the effects of lupus. Story
Medical Device News
@FierceMedDev: ICYMI yesterday: Intraocular lens maker Staar Surgical gets warning letter over its manufacturing practices. Story | Follow @FierceMedDev
@VarunSaxena2: UPDATED w/results of the sale: Trovagene raises $23M in follow-on share offering for urine-based cancer diagnostic. FierceDiagnostics article | Follow @VarunSaxena2
@EmilyWFierce: Scientists unveil new biomarker for early detection of dementia through blood test. Report | Follow @EmilyWFierce
> Bayer starts reorg as it explores sale of diabetes biz. More
> Invitae's $102M IPO stands alone as three med tech IPOs remain sidelined. Story
> Sanofi backs Europe's first remote clinical trial--for a smart glucose monitor. Article
Biotech News
@FierceBiotech: ICYMI yesterday: $SNY drops the ax on 100 R&D staffers in Boston reorganization. Article | Follow @FierceBiotech
@JohnCFierce: J&J's R&D group crafts 3 new platforms to guide global drug development. Story | Follow @JohnCFierce
@DamianFierce: Things @AcordaNews has: 1. An Instagram account 2. A softball team called "COHEN'S CRUSHERS." Picture | Follow @DamianFierce
> Shire hails its best-ever pipeline with a 'busy' R&D year ahead. News
> Eisai says its new thyroid cancer drug is a sure blockbuster. Article
> Will FDA advisers shoot down Amgen's cancer vaccine? More
Vaccines News
> Advaxis inks pact with Incyte to test cervical cancer vaccine combo. Item
> Vaxxas scores $20M to develop needle-free vaccines. Article
> Serum Institute and Cipla in early merger talks. More
> GSK nabs pipeline prospects, conjugate vaccine tech with GlycoVaxyn buyout. Story
> GSK lays off 27 vaccine researchers in Montana. Report
Pharma Manufacturing News
> Genzyme biologics plant continues to pay off for Sanofi. Report
> Hospira recalls 60 lots of pain drug. Report
> Another doctor convicted for selling foreign-made drugs. Article
> GSK resolving shortage of Nicorette Lozenges. Story
> Report: 'Carrot and stick' needed to deal with drug shortages. More
And Finally… Traces of more than 30 different prescription and over-the-counter drugs were found downstream from septic systems in New England and New York, according to reports from the U.S. Geological Survey. Story